EAGLE PHARMACEUTICALS, INC. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2023.
  • Eagle Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $421K, a 12.3% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $1.51M, a 7.11% increase from 2021.
  • Eagle Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $1.41M, a 6.35% increase from 2020.
  • Eagle Pharmaceuticals, Inc. annual Operating Lease, Payments for 2020 was $1.32M, a 39% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $421K +$46K +12.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q1 2022 $375K +$32K +9.33% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-09
Q1 2021 $343K +$57K +19.9% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-10
Q1 2020 $286K -$1K -0.35% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-11
Q1 2019 $287K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.